CCO members Meghan Bloom, Angela Jarrett, and Anna Sorace presented posters at the 2018 San Antonio Breast Cancer Symposium
Quantitative breast MRI to predict response to neoadjuvant therapy in community imaging centers: Preliminary results. Sorace AG, Virostko J, Wu C, Jarrett AM, Barnes SL, Ekrut D, Patt D, Goodgame B, Avery S, Yankeelov TE. University of Texas at Austin, Austin, TX; Texas Oncology, Austin, TX; Seton Healthcare, Austin, TX; Austin Radiological Association, Austin, TX.
Investigating trastuzumab-induced myeloid cell alterations for improving combination therapy in HER2+ breast cancer. Bloom MJ, Jarrett AM, Triplett TA, Syed AK, Yankeelov TE, Sorace AG. University of Texas, Austin, TX.
A multi-scale mathematical model of combination targeted and cytotoxic therapy to evaluate treatment response in HER2+ breast cancer. Jarrett AM, Shah A, Bloom MJ, Yankeelov TE, Sorace AG. The University of Texas at Austin, Austin, TX.
